Post by CPTx

2,871 followers

š— š—²š—²š˜ š—¼š˜‚š—æ š—–š—µš—¶š—²š—³ š—•š˜‚š˜€š—¶š—»š—²š˜€š˜€ š—¢š—³š—³š—¶š—°š—²š—æ, David Maier, š—®š˜ š—•š—œš—¢ š—œš—»š˜š—²š—暝—»š—®š˜š—¶š—¼š—»š—®š—¹ š—–š—¼š—»š˜ƒš—²š—»š˜š—¶š—¼š—» š—»š—²š˜…š˜ š˜„š—²š—²š—ø! At CPTx, we're developing non-viral, in vivo CAR T therapies powered by immune-quiet DNA. We look forward to engaging in meaningful discussions about CAR T, single-stranded DNA technologies and the future of genetic medicines. šŸ“ San Diego Convetion Center | June 22-25 If you are attending and would like to connect, feel free to reach out through the conference system or contact David directly. #CPTx #InVivo #CART #GeneTherapy #CellTherapy #ssDNA #PrecisionMedicine #BIO2026 #DrivenbyPurpose

Post content